{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:46:18Z","timestamp":1793407578095,"version":"4.5.0"},"reference-count":200,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103021"],"award-info":[{"award-number":["82103021"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M721725"],"award-info":[{"award-number":["2022M721725"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07690-5","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T06:55:33Z","timestamp":1768200933000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Exercise-modulated IL-6 in cancer cachexia: molecular mechanisms and therapeutic potential"],"prefix":"10.1186","volume":"24","author":[{"given":"Shujuan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9897-6789","authenticated-orcid":false,"given":"Shengguang","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"7690_CR1","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1634\/theoncologist.2016-0066","volume":"21","author":"HN Rier","year":"2016","unstructured":"Rier HN, Jager A, Sleijfer S, Maier AB, Levin MD. The prevalence and prognostic value of low muscle mass in cancer patients: A review of the literature. Oncologist. 2016;21:1396\u2013409.","journal-title":"Oncologist"},{"key":"7690_CR2","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1042\/BCJ20201009","volume":"478","author":"Y Li","year":"2021","unstructured":"Li Y, Jin H, Chen Y, Huang T, Mi Y, Zou Z. Cancer cachexia: molecular mechanism and Pharmacological management. Biochem J. 2021;478:1663\u201388.","journal-title":"Biochem J"},{"key":"7690_CR3","doi-asserted-by":"publisher","first-page":"100282","DOI":"10.1016\/j.advnut.2024.100282","volume":"15","author":"T Takaoka","year":"2024","unstructured":"Takaoka T, Yaegashi A, Watanabe D. Prevalence of and survival with cachexia among patients with cancer: A systematic review and Meta-Analysis. Adv Nutr. 2024;15:100282.","journal-title":"Adv Nutr"},{"key":"7690_CR4","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","volume":"12","author":"K Fearon","year":"2011","unstructured":"Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12:489\u201395.","journal-title":"Lancet Oncol"},{"key":"7690_CR5","first-page":"1569","volume":"21","author":"O Wallengren","year":"2013","unstructured":"Wallengren O, Lundholm K, Bosaeus I. Diagnostic criteria of cancer cachexia: relation to quality of life, exercise capacity and survival in unselected palliative care patients. Support Care Cancer. 2013;21:1569\u201377.","journal-title":"Support Care Cancer"},{"key":"7690_CR6","doi-asserted-by":"publisher","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","volume":"4","author":"VE Baracos","year":"2018","unstructured":"Baracos VE, Martin L, Korc M, Guttridge DC, Fearon KCH. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.","journal-title":"Nat Rev Dis Primers"},{"key":"7690_CR7","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/cas.16078","volume":"115","author":"Y Nakamura","year":"2024","unstructured":"Nakamura Y, Saldajeno DP, Kawaguchi K, Kawaoka S. Progressive, multi-organ, and multi-layered nature of cancer cachexia. Cancer Sci. 2024;115:715\u201322.","journal-title":"Cancer Sci"},{"key":"7690_CR8","first-page":"4009","volume":"291","author":"S Agca","year":"2024","unstructured":"Agca S, Kir S. The role of interleukin-6 family cytokines in cancer cachexia. Febs J. 2024;291:4009\u201323.","journal-title":"Febs J"},{"key":"7690_CR9","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/JES.0b013e3181f44f11","volume":"38","author":"JA Carson","year":"2010","unstructured":"Carson JA, Baltgalvis KA. Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev. 2010;38:168\u201376.","journal-title":"Exerc Sport Sci Rev"},{"key":"7690_CR10","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12944-018-0657-0","volume":"17","author":"J Han","year":"2018","unstructured":"Han J, Meng Q, Shen L, Wu G. Interleukin-6 induces fat loss in cancer cachexia by promoting white adipose tissue lipolysis and Browning. Lipids Health Dis. 2018;17:14.","journal-title":"Lipids Health Dis"},{"key":"7690_CR11","doi-asserted-by":"publisher","first-page":"5372","DOI":"10.1158\/0008-5472.CAN-15-3152","volume":"76","author":"JL Chen","year":"2016","unstructured":"Chen JL, Walton KL, Qian H, Colgan TD, Hagg A, Watt MJ, Harrison CA, Gregorevic P. Differential effects of IL6 and activin A in the development of Cancer-Associated cachexia. Cancer Res. 2016;76:5372\u201382.","journal-title":"Cancer Res"},{"key":"7690_CR12","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1016\/j.celrep.2019.02.044","volume":"26","author":"D Mishra","year":"2019","unstructured":"Mishra D, Richard JE, Maric I, Porteiro B, H\u00e4ring M, Kooijman S, Musovic S, Eerola K, L\u00f3pez-Ferreras L, Peris E, et al. Parabrachial Interleukin-6 reduces body weight and food intake and increases thermogenesis to regulate energy metabolism. Cell Rep. 2019;26:3011\u2013e30263015.","journal-title":"Cell Rep"},{"key":"7690_CR13","first-page":"312","volume":"15","author":"S Iwase","year":"2004","unstructured":"Iwase S, Murakami T, Saito Y, Nakagawa K. Steep elevation of blood interleukin-6 (IL-6) associated only with late stages of cachexia in cancer patients. Eur Cytokine Netw. 2004;15:312\u20136.","journal-title":"Eur Cytokine Netw"},{"key":"7690_CR14","first-page":"3071","volume":"21","author":"SY Suh","year":"2013","unstructured":"Suh SY, Choi YS, Yeom CH, Kwak SM, Yoon HM, Kim DG, Koh SJ, Park J, Lee MA, Lee YJ, et al. Interleukin-6 but not tumour necrosis factor-alpha predicts survival in patients with advanced cancer. Support Care Cancer. 2013;21:3071\u20137.","journal-title":"Support Care Cancer"},{"key":"7690_CR15","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","volume":"8","author":"S Rose-John","year":"2012","unstructured":"Rose-John S. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci. 2012;8:1237\u201347.","journal-title":"Int J Biol Sci"},{"key":"7690_CR16","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1042\/bse0420105","volume":"42","author":"BK Pedersen","year":"2006","unstructured":"Pedersen BK. The anti-inflammatory effect of exercise: its role in diabetes and cardiovascular disease control. Essays Biochem. 2006;42:105\u201317.","journal-title":"Essays Biochem"},{"key":"7690_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s12020-013-0038-4","volume":"46","author":"M Molanouri Shamsi","year":"2014","unstructured":"Molanouri Shamsi M, Hassan ZH, Gharakhanlou R, Quinn LS, Azadmanesh K, Baghersad L, Isanejad A, Mahdavi M. Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training. Endocrine. 2014;46:60\u20139.","journal-title":"Endocrine"},{"key":"7690_CR18","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.cyto.2012.10.021","volume":"61","author":"FF Donatto","year":"2013","unstructured":"Donatto FF, Neves RX, Rosa FO, Camargo RG, Ribeiro H, Matos-Neto EM, Seelaender M. Resistance exercise modulates lipid plasma profile and cytokine content in the adipose tissue of tumour-bearing rats. Cytokine. 2013;61:426\u201332.","journal-title":"Cytokine"},{"key":"7690_CR19","doi-asserted-by":"publisher","first-page":"a028415","DOI":"10.1101\/cshperspect.a028415","volume":"10","author":"S Rose-John","year":"2018","unstructured":"Rose-John S. Interleukin-6 family cytokines. Cold Spring Harb Perspect Biol. 2018;10:a028415.","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"Suppl 2","key":"7690_CR20","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar1916","volume":"8","author":"T Kishimoto","year":"2006","unstructured":"Kishimoto T. Interleukin-6: discovery of a pleiotropic cytokine. Arthritis Res Ther. 2006;8(Suppl 2):S2.","journal-title":"Arthritis Res Ther"},{"key":"7690_CR21","doi-asserted-by":"publisher","first-page":"a016295","DOI":"10.1101\/cshperspect.a016295","volume":"6","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6:a016295.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"7690_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1158\/2326-6066.CIR-14-0022","volume":"2","author":"T Tanaka","year":"2014","unstructured":"Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6. Cancer Immunol Res. 2014;2:288\u201394.","journal-title":"Cancer Immunol Res"},{"key":"7690_CR23","doi-asserted-by":"publisher","first-page":"115327","DOI":"10.1016\/j.bmc.2020.115327","volume":"28","author":"S Kaur","year":"2020","unstructured":"Kaur S, Bansal Y, Kumar R, Bansal G. A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors. Bioorg Med Chem. 2020;28:115327.","journal-title":"Bioorg Med Chem"},{"key":"7690_CR24","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","volume":"1813","author":"J Scheller","year":"2011","unstructured":"Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta. 2011;1813:878\u201388.","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 3","key":"7690_CR25","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1186\/ar565","volume":"4","author":"T Naka","year":"2002","unstructured":"Naka T, Nishimoto N, Kishimoto T. The paradigm of IL-6: from basic science to medicine. Arthritis Res. 2002;4(Suppl 3):S233\u2013242.","journal-title":"Arthritis Res"},{"key":"7690_CR26","doi-asserted-by":"publisher","first-page":"2688","DOI":"10.2337\/db05-1404","volume":"55","author":"AL Carey","year":"2006","unstructured":"Carey AL, Steinberg GR, Macaulay SL, Thomas WG, Holmes AG, Ramm G, Prelovsek O, Hohnen-Behrens C, Watt MJ, James DE, et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes. 2006;55:2688\u201397.","journal-title":"Diabetes"},{"key":"7690_CR27","doi-asserted-by":"publisher","first-page":"E251","DOI":"10.1152\/ajpendo.00448.2004","volume":"289","author":"C Weigert","year":"2005","unstructured":"Weigert C, Hennige AM, Brodbeck K, H\u00e4ring HU, Schleicher ED. Interleukin-6 acts as insulin sensitizer on glycogen synthesis in human skeletal muscle cells by phosphorylation of Ser473 of Akt. Am J Physiol Endocrinol Metab. 2005;289:E251\u2013257.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7690_CR28","doi-asserted-by":"publisher","first-page":"M487","DOI":"10.1093\/gerona\/54.10.M487","volume":"54","author":"SG Leveille","year":"1999","unstructured":"Leveille SG, Guralnik JM, Hochberg M, Hirsch R, Ferrucci L, Langlois J, Rantanen T, Ling S. Low back pain and disability in older women: independent association with difficulty but not inability to perform daily activities. J Gerontol Biol Sci Med Sci. 1999;54:M487\u2013493.","journal-title":"J Gerontol Biol Sci Med Sci"},{"key":"7690_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1042\/bj2650621","volume":"265","author":"PC Heinrich","year":"1990","unstructured":"Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J. 1990;265:621\u201336.","journal-title":"Biochem J"},{"key":"7690_CR30","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1172\/JCI200420945","volume":"113","author":"E Nemeth","year":"2004","unstructured":"Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, Ganz T. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone Hepcidin. J Clin Invest. 2004;113:1271\u20136.","journal-title":"J Clin Invest"},{"key":"7690_CR31","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1182\/blood.V74.4.1241.1241","volume":"74","author":"T Ishibashi","year":"1989","unstructured":"Ishibashi T, Kimura H, Shikama Y, Uchida T, Kariyone S, Hirano T, Kishimoto T, Takatsuki F, Akiyama Y. Interleukin-6 is a potent thrombopoietic factor in vivo in mice. Blood. 1989;74:1241\u20134.","journal-title":"Blood"},{"key":"7690_CR32","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1113\/jphysiol.2002.021022","volume":"543","author":"D Lyngs\u00f8","year":"2002","unstructured":"Lyngs\u00f8 D, Simonsen L, B\u00fclow J. Metabolic effects of interleukin-6 in human splanchnic and adipose tissue. J Physiol. 2002;543:379\u201386.","journal-title":"J Physiol"},{"key":"7690_CR33","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.1210\/jc.2002-021687","volume":"88","author":"G van Hall","year":"2003","unstructured":"van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P, Hiscock N, M\u00f8ller K, Saltin B, Febbraio MA, Pedersen BK. Interleukin-6 stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab. 2003;88:3005\u201310.","journal-title":"J Clin Endocrinol Metab"},{"key":"7690_CR34","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/00000658-199404000-00001","volume":"219","author":"JS Falconer","year":"1994","unstructured":"Falconer JS, Fearon KC, Plester CE, Ross JA, Carter DC. Cytokines, the acute-phase response, and resting energy expenditure in cachectic patients with pancreatic cancer. Ann Surg. 1994;219:325\u201331.","journal-title":"Ann Surg"},{"key":"7690_CR35","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1593\/neo.13706","volume":"15","author":"Q Chang","year":"2013","unstructured":"Chang Q, Bournazou E, Sansone P, Berishaj M, Gao SP, Daly L, Wels J, Theilen T, Granitto S, Zhang X, et al. The IL-6\/JAK\/Stat3 feed-forward loop drives tumorigenesis and metastasis. Neoplasia. 2013;15:848\u201362.","journal-title":"Neoplasia"},{"key":"7690_CR36","doi-asserted-by":"publisher","first-page":"11553","DOI":"10.1007\/s13277-016-5098-7","volume":"37","author":"N Kumari","year":"2016","unstructured":"Kumari N, Dwarakanath BS, Das A, Bhatt AN. Role of interleukin-6 in cancer progression and therapeutic resistance. Tumour Biol. 2016;37:11553\u201372.","journal-title":"Tumour Biol"},{"key":"7690_CR37","doi-asserted-by":"publisher","first-page":"5577","DOI":"10.1210\/jc.2004-0603","volume":"89","author":"ME Trujillo","year":"2004","unstructured":"Trujillo ME, Sullivan S, Harten I, Schneider SH, Greenberg AS, Fried SK. Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J Clin Endocrinol Metab. 2004;89:5577\u201382.","journal-title":"J Clin Endocrinol Metab"},{"key":"7690_CR38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0006-8993(98)01091-9","volume":"815","author":"J Wang","year":"1999","unstructured":"Wang J, Dunn AJ. The role of interleukin-6 in the activation of the hypothalamo-pituitary-adrenocortical axis and brain indoleamines by endotoxin and interleukin-1 beta. Brain Res. 1999;815:337\u201348.","journal-title":"Brain Res"},{"key":"7690_CR39","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/S0197-0186(98)00016-3","volume":"33","author":"J Wang","year":"1998","unstructured":"Wang J, Dunn AJ. Mouse interleukin-6 stimulates the HPA axis and increases brain Tryptophan and serotonin metabolism. Neurochem Int. 1998;33:143\u201354.","journal-title":"Neurochem Int"},{"key":"7690_CR40","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1111\/febs.12338","volume":"280","author":"P Mu\u00f1oz-C\u00e1noves","year":"2013","unstructured":"Mu\u00f1oz-C\u00e1noves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? Febs J. 2013;280:4131\u201348.","journal-title":"Febs J"},{"issue":"Pt 1","key":"7690_CR41","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/j.1469-7793.1999.287ad.x","volume":"515","author":"K Ostrowski","year":"1999","unstructured":"Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol. 1999;515(Pt 1):287\u201391.","journal-title":"J Physiol"},{"key":"7690_CR42","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s00421-012-2432-7","volume":"113","author":"S Abedelmalek","year":"2013","unstructured":"Abedelmalek S, Chtourou H, Aloui A, Aouichaoui C, Souissi N, Tabka Z. Effect of time of day and partial sleep deprivation on plasma concentrations of IL-6 during a short-term maximal performance. Eur J Appl Physiol. 2013;113:241\u20138.","journal-title":"Eur J Appl Physiol"},{"key":"7690_CR43","doi-asserted-by":"publisher","first-page":"R296","DOI":"10.1152\/ajpregu.00147.2019","volume":"318","author":"HN Daou","year":"2020","unstructured":"Daou HN. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation. Am J Physiol Regul Integr Comp Physiol. 2020;318:R296\u2013310.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"7690_CR44","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.numecd.2009.04.015","volume":"20","author":"S Balducci","year":"2010","unstructured":"Balducci S, Zanuso S, Nicolucci A, Fernando F, Cavallo S, Cardelli P, Fallucca S, Alessi E, Letizia C, Jimenez A, et al. Anti-inflammatory effect of exercise training in subjects with type 2 diabetes and the metabolic syndrome is dependent on exercise modalities and independent of weight loss. Nutr Metab Cardiovasc Dis. 2010;20:608\u201317.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"7690_CR45","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrclinonc.2012.209","volume":"10","author":"K Fearon","year":"2013","unstructured":"Fearon K, Arends J, Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nat Rev Clin Oncol. 2013;10:90\u20139.","journal-title":"Nat Rev Clin Oncol"},{"key":"7690_CR46","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1172\/JCI118398","volume":"97","author":"T Tsujinaka","year":"1996","unstructured":"Tsujinaka T, Fujita J, Ebisui C, Yano M, Kominami E, Suzuki K, Tanaka K, Katsume A, Ohsugi Y, Shiozaki H, Monden M. Interleukin 6 receptor antibody inhibits muscle atrophy and modulates proteolytic systems in Interleukin 6 Transgenic mice. J Clin Invest. 1996;97:244\u20139.","journal-title":"J Clin Invest"},{"key":"7690_CR47","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA. IL-6 as a keystone cytokine in health and disease. Nat Immunol. 2015;16:448\u201357.","journal-title":"Nat Immunol"},{"key":"7690_CR48","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","volume":"303","author":"A Bonetto","year":"2012","unstructured":"Bonetto A, Aydogdu T, Jin X, Zhang Z, Zhan R, Puzis L, Koniaris LG, Zimmers TA. JAK\/STAT3 pathway Inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab. 2012;303:E410\u2013421.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7690_CR49","doi-asserted-by":"publisher","first-page":"e22538","DOI":"10.1371\/journal.pone.0022538","volume":"6","author":"A Bonetto","year":"2011","unstructured":"Bonetto A, Aydogdu T, Kunzevitzky N, Guttridge DC, Khuri S, Koniaris LG, Zimmers TA. STAT3 activation in skeletal muscle links muscle wasting and the acute phase response in cancer cachexia. PLoS ONE. 2011;6:e22538.","journal-title":"PLoS ONE"},{"key":"7690_CR50","doi-asserted-by":"publisher","first-page":"2313671","DOI":"10.1080\/07853890.2024.2313671","volume":"56","author":"H Xu","year":"2024","unstructured":"Xu H, Du Z, Li Z, Liu X, Li X, Zhang X, Ma J. MUC1-EGFR crosstalk with IL-6 by activating NF-\u03baB and MAPK pathways to regulate the stemness and paclitaxel-resistance of lung adenocarcinoma. Ann Med. 2024;56:2313671.","journal-title":"Ann Med"},{"key":"7690_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.canlet.2016.02.048","volume":"375","author":"R Bharti","year":"2016","unstructured":"Bharti R, Dey G, Mandal M. Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement. Cancer Lett. 2016;375:51\u201361.","journal-title":"Cancer Lett"},{"key":"7690_CR52","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.7150\/ijbs.94339","volume":"20","author":"JH Guo","year":"2024","unstructured":"Guo JH, Thuong LHH, Jiang YJ, Huang CL, Huang YW, Cheng FJ, Liu PI, Liu CL, Huang WC, Tang CH. Cigarette smoke promotes IL-6-dependent lung cancer migration and osteolytic bone metastasis. Int J Biol Sci. 2024;20:3257\u201368.","journal-title":"Int J Biol Sci"},{"key":"7690_CR53","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1681\/ASN.2008060628","volume":"20","author":"L Zhang","year":"2009","unstructured":"Zhang L, Du J, Hu Z, Han G, Delafontaine P, Garcia G, Mitch WE. IL-6 and serum amyloid A synergy mediates angiotensin II-induced muscle wasting. J Am Soc Nephrol. 2009;20:604\u201312.","journal-title":"J Am Soc Nephrol"},{"key":"7690_CR54","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.cmet.2013.07.012","volume":"18","author":"L Zhang","year":"2013","unstructured":"Zhang L, Pan J, Dong Y, Tweardy DJ, Dong Y, Garibotto G, Mitch WE. Stat3 activation links a C\/EBP\u03b4 to myostatin pathway to stimulate loss of muscle mass. Cell Metab. 2013;18:368\u201379.","journal-title":"Cell Metab"},{"key":"7690_CR55","doi-asserted-by":"publisher","first-page":"622","DOI":"10.15252\/emmm.201607052","volume":"9","author":"JF Ma","year":"2017","unstructured":"Ma JF, Sanchez BJ, Hall DT, Tremblay AK, Di Marco S, Gallouzi IE. STAT3 promotes IFN\u03b3\/TNF\u03b1-induced muscle wasting in an NF-\u03baB-dependent and IL-6-independent manner. EMBO Mol Med. 2017;9:622\u201337.","journal-title":"EMBO Mol Med"},{"key":"7690_CR56","doi-asserted-by":"publisher","first-page":"1608612","DOI":"10.3389\/fendo.2025.1608612","volume":"16","author":"X Lv","year":"2025","unstructured":"Lv X, Ding S. Unraveling the role of STAT3 in cancer cachexia: pathogenic mechanisms and therapeutic opportunities. Front Endocrinol (Lausanne). 2025;16:1608612.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"7690_CR57","doi-asserted-by":"publisher","first-page":"C717","DOI":"10.1152\/ajpcell.00305.2012","volume":"304","author":"BR McKay","year":"2013","unstructured":"McKay BR, Ogborn DI, Baker JM, Toth KG, Tarnopolsky MA, Parise G. Elevated SOCS3 and altered IL-6 signaling is associated with age-related human muscle stem cell dysfunction. Am J Physiol Cell Physiol. 2013;304:C717\u2013728.","journal-title":"Am J Physiol Cell Physiol"},{"key":"7690_CR58","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-023-01454-0","volume":"16","author":"T Setiawan","year":"2023","unstructured":"Setiawan T, Sari IN, Wijaya YT, Julianto NM, Muhammad JA, Lee H, Chae JH, Kwon HY. Cancer cachexia: molecular mechanisms and treatment strategies. J Hematol Oncol. 2023;16:54.","journal-title":"J Hematol Oncol"},{"key":"7690_CR59","doi-asserted-by":"publisher","first-page":"597675","DOI":"10.3389\/fphys.2020.597675","volume":"11","author":"JM Webster","year":"2020","unstructured":"Webster JM, Kempen L, Hardy RS, Langen RCJ. Inflammation and skeletal muscle wasting during cachexia. Front Physiol. 2020;11:597675.","journal-title":"Front Physiol"},{"key":"7690_CR60","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1186\/1471-2407-14-997","volume":"14","author":"SM Judge","year":"2014","unstructured":"Judge SM, Wu CL, Beharry AW, Roberts BM, Ferreira LF, Kandarian SC, Judge AR. Genome-wide identification of FoxO-dependent gene networks in skeletal muscle during C26 cancer cachexia. BMC Cancer. 2014;14:997.","journal-title":"BMC Cancer"},{"key":"7690_CR61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2044-5040-2-14","volume":"2","author":"JP White","year":"2012","unstructured":"White JP, Puppa MJ, Sato S, Gao S, Price RL, Baynes JW, Kostek MC, Matesic LE, Carson JA. IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin\/+ mouse. Skelet Muscle. 2012;2:14.","journal-title":"Skelet Muscle"},{"key":"7690_CR62","doi-asserted-by":"publisher","first-page":"R201","DOI":"10.1152\/ajpregu.00300.2010","volume":"300","author":"JP White","year":"2011","unstructured":"White JP, Baltgalvis KA, Puppa MJ, Sato S, Baynes JW, Carson JA. Muscle oxidative capacity during IL-6-dependent cancer cachexia. Am J Physiol Regul Integr Comp Physiol. 2011;300:R201\u2013211.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"7690_CR63","unstructured":"Puppa M. The regulation of skeletal muscle mass and mitochondrial biogenesis by gp130\/STAT3 signaling during cancer cachexia. 2014."},{"key":"7690_CR64","doi-asserted-by":"publisher","first-page":"9148246","DOI":"10.1155\/2022\/9148246","volume":"2022","author":"B Yang","year":"2022","unstructured":"Yang B, Yang X, Sun X, Shi J, Shen Y, Chen R. IL-6 deficiency attenuates skeletal muscle atrophy by inhibiting mitochondrial ROS production through the upregulation of PGC-1\u03b1 in septic mice. Oxid Med Cell Longev. 2022;2022:9148246.","journal-title":"Oxid Med Cell Longev"},{"key":"7690_CR65","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2007.11.011","volume":"7","author":"AL Serrano","year":"2008","unstructured":"Serrano AL, Baeza-Raja B, Perdiguero E, Jard\u00ed M, Mu\u00f1oz-C\u00e1noves P. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab. 2008;7:33\u201344.","journal-title":"Cell Metab"},{"key":"7690_CR66","doi-asserted-by":"publisher","first-page":"5273","DOI":"10.3390\/ijms20215273","volume":"20","author":"PJ Steyn","year":"2019","unstructured":"Steyn PJ, Dzobo K, Smith RI, Myburgh KH. Interleukin-6 induces myogenic differentiation via JAK2-STAT3 signaling in mouse C2C12 myoblast cell line and primary human myoblasts. Int J Mol Sci. 2019;20:5273.","journal-title":"Int J Mol Sci"},{"key":"7690_CR67","doi-asserted-by":"publisher","first-page":"e202302503","DOI":"10.26508\/lsa.202302503","volume":"7","author":"G Catarinella","year":"2024","unstructured":"Catarinella G, Bracaglia A, Skafida E, Procopio P, Ruggieri V, Parisi C, De Bardi M, Borsellino G, Madaro L, Puri PL, et al. STAT3 Inhibition recovers regeneration of aged muscles by restoring autophagy in muscle stem cells. Life Sci Alliance. 2024;7:e202302503.","journal-title":"Life Sci Alliance"},{"issue":"Suppl 10","key":"7690_CR68","first-page":"43","volume":"57","author":"AM Petersen","year":"2006","unstructured":"Petersen AM, Pedersen BK. The role of IL-6 in mediating the anti-inflammatory effects of exercise. J Physiol Pharmacol. 2006;57(Suppl 10):43\u201351.","journal-title":"J Physiol Pharmacol"},{"key":"7690_CR69","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1101\/gad.276733.115","volume":"30","author":"M Petruzzelli","year":"2016","unstructured":"Petruzzelli M, Wagner EF. Mechanisms of metabolic dysfunction in cancer-associated cachexia. Genes Dev. 2016;30:489\u2013501.","journal-title":"Genes Dev"},{"key":"7690_CR70","doi-asserted-by":"publisher","first-page":"e140327","DOI":"10.1172\/jci.insight.140327","volume":"5","author":"T Thomas","year":"2020","unstructured":"Thomas T, Stefanoni D, Reisz JA, Nemkov T, Bertolone L, Francis RO, Hudson KE, Zimring JC, Hansen KC, Hod EA, et al. COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. JCI Insight. 2020;5:e140327.","journal-title":"JCI Insight"},{"key":"7690_CR71","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1249\/MSS.0000000000000660","volume":"47","author":"RE Macpherson","year":"2015","unstructured":"Macpherson RE, Huber JS, Frendo-Cumbo S, Simpson JA, Wright DC. Adipose tissue insulin action and IL-6 signaling after exercise in obese mice. Med Sci Sports Exerc. 2015;47:2034\u201342.","journal-title":"Med Sci Sports Exerc"},{"key":"7690_CR72","doi-asserted-by":"publisher","first-page":"e84910","DOI":"10.1371\/journal.pone.0084910","volume":"9","author":"JG Knudsen","year":"2014","unstructured":"Knudsen JG, Murholm M, Carey AL, Biens\u00f8 RS, Basse AL, Allen TL, Hidalgo J, Kingwell BA, Febbraio MA, Hansen JB, Pilegaard H. Role of IL-6 in exercise training- and cold-induced UCP1 expression in subcutaneous white adipose tissue. PLoS ONE. 2014;9:e84910.","journal-title":"PLoS ONE"},{"key":"7690_CR73","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","volume":"20","author":"M Petruzzelli","year":"2014","unstructured":"Petruzzelli M, Schweiger M, Schreiber R, Campos-Olivas R, Tsoli M, Allen J, Swarbrick M, Rose-John S, Rincon M, Robertson G, et al. A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. Cell Metab. 2014;20:433\u201347.","journal-title":"Cell Metab"},{"key":"7690_CR74","doi-asserted-by":"publisher","first-page":"4682","DOI":"10.1038\/s41467-024-48971-1","volume":"15","author":"Q Sun","year":"2024","unstructured":"Sun Q, van de Lisdonk D, Ferrer M, Gegenhuber B, Wu M, Park Y, Tuveson DA, Tollkuhn J, Janowitz T, Li B. Area Postrema neurons mediate interleukin-6 function in cancer cachexia. Nat Commun. 2024;15:4682.","journal-title":"Nat Commun"},{"key":"7690_CR75","doi-asserted-by":"publisher","first-page":"eadm8857","DOI":"10.1126\/science.adm8857","volume":"388","author":"XA Zhu","year":"2025","unstructured":"Zhu XA, Starosta S, Ferrer M, Hou J, Chevy Q, Lucantonio F, Mu\u00f1oz-Casta\u00f1eda R, Zhang F, Zang K, Zhao X, et al. A neuroimmune circuit mediates cancer cachexia-associated apathy. Science. 2025;388:eadm8857.","journal-title":"Science"},{"key":"7690_CR76","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1126\/science.adw8833","volume":"388","author":"JW Dalley","year":"2025","unstructured":"Dalley JW, Lynall ME. How does cancer affect motivation? Science. 2025;388:150\u20131.","journal-title":"Science"},{"key":"7690_CR77","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1523\/JNEUROSCI.2830-13.2014","volume":"34","author":"IL Campbell","year":"2014","unstructured":"Campbell IL, Erta M, Lim SL, Frausto R, May U, Rose-John S, Scheller J, Hidalgo J. Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain. J Neurosci. 2014;34:2503\u201313.","journal-title":"J Neurosci"},{"key":"7690_CR78","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1742-2094-8-54","volume":"8","author":"MD Burton","year":"2011","unstructured":"Burton MD, Sparkman NL, Johnson RW. Inhibition of interleukin-6 trans-signaling in the brain facilitates recovery from lipopolysaccharide-induced sickness behavior. J Neuroinflammation. 2011;8:54.","journal-title":"J Neuroinflammation"},{"key":"7690_CR79","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1172\/JCI57158","volume":"121","author":"SA Jones","year":"2011","unstructured":"Jones SA, Scheller J, Rose-John S. Therapeutic strategies for the clinical Blockade of IL-6\/gp130 signaling. J Clin Invest. 2011;121:3375\u201383.","journal-title":"J Clin Invest"},{"key":"7690_CR80","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","volume":"79","author":"L Liu","year":"2022","unstructured":"Liu L, Shi Z, Ji X, Zhang W, Luan J, Zahr T, Qiang L. Adipokines, adiposity, and atherosclerosis. Cell Mol Life Sci. 2022;79:272.","journal-title":"Cell Mol Life Sci"},{"key":"7690_CR81","first-page":"99","volume":"43","author":"A Stofkova","year":"2009","unstructured":"Stofkova A, Skurlova M, Kiss A, Zelezna B, Zorad S, Jurcovicova J. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity. Endocr Regul. 2009;43:99\u2013106.","journal-title":"Endocr Regul"},{"key":"7690_CR82","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/j.bbi.2007.12.006","volume":"22","author":"LM Harden","year":"2008","unstructured":"Harden LM, du Plessis I, Poole S, Laburn HP. Interleukin (IL)-6 and IL-1 beta act synergistically within the brain to induce sickness behavior and fever in rats. Brain Behav Immun. 2008;22:838\u201349.","journal-title":"Brain Behav Immun"},{"key":"7690_CR83","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1742-2094-10-40","volume":"10","author":"AL Beynon","year":"2013","unstructured":"Beynon AL, Brown MR, Wright R, Rees MI, Sheldon IM, Davies JS. Ghrelin inhibits LPS-induced release of IL-6 from mouse dopaminergic neurones. J Neuroinflammation. 2013;10:40.","journal-title":"J Neuroinflammation"},{"key":"7690_CR84","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.cmet.2018.04.008","volume":"27","author":"L Lang Lehrskov","year":"2018","unstructured":"Lang Lehrskov L, Lyngbaek MP, Soederlund L, Legaard GE, Ehses JA, Heywood SE, Wewer Albrechtsen NJ, Holst JJ, Karstoft K, Pedersen BK, Ellingsgaard H. Interleukin-6 delays gastric emptying in humans with direct effects on glycemic control. Cell Metab. 2018;27:1201\u2013e12111203.","journal-title":"Cell Metab"},{"key":"7690_CR85","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0304-3835(02)00006-X","volume":"180","author":"MC Gomes-Marcondes","year":"2002","unstructured":"Gomes-Marcondes MC, Tisdale MJ. Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress. Cancer Lett. 2002;180:69\u201374.","journal-title":"Cancer Lett"},{"key":"7690_CR86","first-page":"1521","volume":"18","author":"N Fortunati","year":"2007","unstructured":"Fortunati N, Manti R, Birocco N, Pugliese M, Brignardello E, Ciuffreda L, Catalano MG, Aragno M, Boccuzzi G. Pro-inflammatory cytokines and oxidative stress\/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Oncol Rep. 2007;18:1521\u20137.","journal-title":"Oncol Rep"},{"key":"7690_CR87","doi-asserted-by":"crossref","unstructured":"VanderVeen BN, Fix DK, Carson JA. Disrupted skeletal muscle mitochondrial dynamics, mitophagy, and biogenesis during cancer cachexia: a role for inflammation. Oxid Med Cell Longev 2017;2017:3292087.","DOI":"10.1155\/2017\/3292087"},{"key":"7690_CR88","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12964-021-00738-7","volume":"19","author":"L Zhou","year":"2021","unstructured":"Zhou L, Zhang YF, Yang FH, Mao HQ, Chen Z, Zhang L. Mitochondrial DNA leakage induces odontoblast inflammation via the cGAS-STING pathway. Cell Commun Signal. 2021;19:58.","journal-title":"Cell Commun Signal"},{"key":"7690_CR89","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/antiox10030476","volume":"10","author":"DY Lee","year":"2021","unstructured":"Lee DY, Chun YS, Kim JK, Lee JO, Lee YJ, Ku SK, Shim SM. Curcumin ameliorated oxidative stress and Inflammation-Related muscle disorders in C2C12 myoblast cells. Antioxid (Basel). 2021;10:476.","journal-title":"Antioxid (Basel)"},{"key":"7690_CR90","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1002\/ijc.24784","volume":"126","author":"ML Asp","year":"2010","unstructured":"Asp ML, Tian M, Wendel AA, Belury MA. Evidence for the contribution of insulin resistance to the development of cachexia in tumor-bearing mice. Int J Cancer. 2010;126:756\u201363.","journal-title":"Int J Cancer"},{"key":"7690_CR91","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1128\/MCB.24.12.5434-5446.2004","volume":"24","author":"K Ueki","year":"2004","unstructured":"Ueki K, Kondo T, Kahn CR. Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through Inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms. Mol Cell Biol. 2004;24:5434\u201346.","journal-title":"Mol Cell Biol"},{"key":"7690_CR92","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature05485","volume":"444","author":"GS Hotamisligil","year":"2006","unstructured":"Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860\u20137.","journal-title":"Nature"},{"key":"7690_CR93","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.2337\/diabetes.52.11.2784","volume":"52","author":"PJ Klover","year":"2003","unstructured":"Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes. 2003;52:2784\u20139.","journal-title":"Diabetes"},{"key":"7690_CR94","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2337\/diabetes.51.12.3391","volume":"51","author":"JJ Senn","year":"2002","unstructured":"Senn JJ, Klover PJ, Nowak IA, Mooney RA. Interleukin-6 induces cellular insulin resistance in hepatocytes. Diabetes. 2002;51:3391\u20139.","journal-title":"Diabetes"},{"key":"7690_CR95","doi-asserted-by":"publisher","first-page":"13740","DOI":"10.1074\/jbc.M210689200","volume":"278","author":"JJ Senn","year":"2003","unstructured":"Senn JJ, Klover PJ, Nowak IA, Zimmers TA, Koniaris LG, Furlanetto RW, Mooney RA. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem. 2003;278:13740\u20136.","journal-title":"J Biol Chem"},{"key":"7690_CR96","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1074\/jbc.M708568200","volume":"283","author":"J-H Kim","year":"2008","unstructured":"Kim J-H, Kim JE, Liu H-Y, Cao W, Chen J. Regulation of interleukin-6-induced hepatic insulin resistance by mammalian target of Rapamycin through the STAT3-SOCS3 pathway. J Biol Chem. 2008;283:708\u201315.","journal-title":"J Biol Chem"},{"key":"7690_CR97","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1615\/CritRevOncog.v17.i3.40","volume":"17","author":"N Johns","year":"2012","unstructured":"Johns N, Greig C, Fearon KC. Is tissue cross-talk important in cancer cachexia? Crit Rev Oncog. 2012;17:263\u201376.","journal-title":"Crit Rev Oncog"},{"key":"7690_CR98","doi-asserted-by":"publisher","first-page":"e20190450","DOI":"10.1084\/jem.20190450","volume":"218","author":"JE Rupert","year":"2021","unstructured":"Rupert JE, Narasimhan A, Jengelley DHA, Jiang Y, Liu J, Au E, Silverman LM, Sandusky G, Bonetto A, Cao S, et al. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia. J Exp Med. 2021;218:e20190450.","journal-title":"J Exp Med"},{"key":"7690_CR99","doi-asserted-by":"crossref","unstructured":"Pettersen K, Andersen S, Degen S, Tadini V, Grosjean J, Hatakeyama S, Tesfahun AN, Moestue S, Kim J, Nonstad U, et al. Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling. Sci Rep. 2017;7:2046.","DOI":"10.1038\/s41598-017-02088-2"},{"key":"7690_CR100","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1096\/fj.03-1259fje","volume":"18","author":"N Hiscock","year":"2004","unstructured":"Hiscock N, Chan MH, Bisucci T, Darby IA, Febbraio MA. Skeletal myocytes are a source of interleukin-6 mRNA expression and protein release during contraction: evidence of fiber type specificity. Faseb J. 2004;18:992\u20134.","journal-title":"Faseb J"},{"key":"7690_CR101","first-page":"968","volume":"12","author":"B Calle-Ciborro","year":"2023","unstructured":"Calle-Ciborro B, Espin-Jaime T, Santos FJ, Gomez-Martin A, Jardin I, Pozo MJ, Rosado JA, Camello PJ, Camello-Almaraz C. Secretion of Interleukin 6 in human skeletal muscle cultures depends on Ca(2+) signalling. Biology (Basel). 2023;12:968.","journal-title":"Biology (Basel)"},{"key":"7690_CR102","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1113\/jphysiol.2005.089193","volume":"566","author":"S Banzet","year":"2005","unstructured":"Banzet S, Koulmann N, Simler N, Birot O, Sanchez H, Chapot R, Peinnequin A, Bigard X. Fibre-type specificity of interleukin-6 gene transcription during muscle contraction in rat: association with calcineurin activity. J Physiol. 2005;566:839\u201347.","journal-title":"J Physiol"},{"key":"7690_CR103","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/j.1748-1716.2011.02344.x","volume":"204","author":"AC Petersen","year":"2012","unstructured":"Petersen AC, McKenna MJ, Medved I, Murphy KT, Brown MJ, Della Gatta P, Cameron-Smith D. Infusion with the antioxidant N-acetylcysteine attenuates early adaptive responses to exercise in human skeletal muscle. Acta Physiol (Oxf). 2012;204:382\u201392.","journal-title":"Acta Physiol (Oxf)"},{"key":"7690_CR104","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s10495-023-01920-7","volume":"29","author":"Y Wu","year":"2024","unstructured":"Wu Y, Yao X, Shi X, Xu Z, Ren J, Shi M, Li M, Liu J, Du X. Myeloma extracellular vesicle-derived RAGE increases inflammatory responses and myotube atrophy in multiple myeloma through activation of the TLR4\/NF-\u03baB p65 pathway. Apoptosis. 2024;29:849\u201364.","journal-title":"Apoptosis"},{"key":"7690_CR105","doi-asserted-by":"publisher","first-page":"E809","DOI":"10.1152\/ajpendo.00560.2003","volume":"286","author":"RA Frost","year":"2004","unstructured":"Frost RA, Nystrom GJ, Lang CH. Epinephrine stimulates IL-6 expression in skeletal muscle and C2C12 myoblasts: role of c-Jun NH2-terminal kinase and histone deacetylase activity. Am J Physiol Endocrinol Metab. 2004;286:E809\u2013817.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7690_CR106","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1113\/jphysiol.2002.030437","volume":"546","author":"JW Helge","year":"2003","unstructured":"Helge JW, Stallknecht B, Pedersen BK, Galbo H, Kiens B, Richter EA. The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle. J Physiol. 2003;546:299\u2013305.","journal-title":"J Physiol"},{"key":"7690_CR107","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fnut.2015.00027","volume":"2","author":"DC Nieman","year":"2015","unstructured":"Nieman DC, Zwetsloot KA, Meaney MP, Lomiwes DD, Hurst SM, Hurst RD. Post-Exercise skeletal muscle glycogen related to plasma cytokines and muscle IL-6 protein Content, but not muscle cytokine mRNA expression. Front Nutr. 2015;2:27.","journal-title":"Front Nutr"},{"key":"7690_CR108","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1113\/jphysiol.2002.032938","volume":"548","author":"A Steensberg","year":"2003","unstructured":"Steensberg A, Fischer CP, Sacchetti M, Keller C, Osada T, Schjerling P, van Hall G, Febbraio MA, Pedersen BK. Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans. J Physiol. 2003;548:631\u20138.","journal-title":"J Physiol"},{"key":"7690_CR109","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1152\/jappl.2001.91.5.2143","volume":"91","author":"RS Mazzeo","year":"2001","unstructured":"Mazzeo RS, Donovan D, Fleshner M, Butterfield GE, Zamudio S, Wolfel EE, Moore LG. Interleukin-6 response to exercise and high-altitude exposure: influence of alpha-adrenergic Blockade. J Appl Physiol (1985). 2001;91:2143\u20139.","journal-title":"J Appl Physiol (1985)"},{"key":"7690_CR110","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1016\/j.nut.2014.03.019","volume":"30","author":"AV Caris","year":"2014","unstructured":"Caris AV, Lira FS, de Mello MT, Oyama LM, dos Santos RV. Carbohydrate and glutamine supplementation modulates the Th1\/Th2 balance after exercise performed at a simulated altitude of 4500 m. Nutrition. 2014;30:1331\u20136.","journal-title":"Nutrition"},{"key":"7690_CR111","doi-asserted-by":"publisher","first-page":"E940","DOI":"10.1152\/ajpendo.00414.2018","volume":"316","author":"P Hojman","year":"2019","unstructured":"Hojman P, Brolin C, N\u00f8rgaard-Christensen N, Dethlefsen C, Lauenborg B, Olsen CK, \u00c5bom MM, Krag T, Gehl J, Pedersen BK. IL-6 release from muscles during exercise is stimulated by lactate-dependent protease activity. Am J Physiol Endocrinol Metab. 2019;316:E940\u20137.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7690_CR112","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.7150\/ijms.83801","volume":"20","author":"J Xu","year":"2023","unstructured":"Xu J, Chen C, Yin J, Fu J, Yang X, Wang B, Yu C, Zheng L, Zhang Z. Lactate-induced MtDNA accumulation activates cGAS-STING signaling and the inflammatory response in Sj\u00f6gren\u2019s syndrome. Int J Med Sci. 2023;20:1256\u201371.","journal-title":"Int J Med Sci"},{"key":"7690_CR113","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.cyto.2015.03.013","volume":"73","author":"A Isanejad","year":"2015","unstructured":"Isanejad A, Saraf ZH, Mahdavi M, Gharakhanlou R, Shamsi MM, Paulsen G. The effect of endurance training and downhill running on the expression of IL-1\u03b2, IL-6, and TNF-\u03b1 and HSP72 in rat skeletal muscle. Cytokine. 2015;73:302\u20138.","journal-title":"Cytokine"},{"key":"7690_CR114","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1152\/japplphysiol.00096.2008","volume":"105","author":"D Markovitch","year":"2008","unstructured":"Markovitch D, Tyrrell RM, Thompson D. Acute moderate-intensity exercise in middle-aged men has neither an anti- nor Proinflammatory effect. J Appl Physiol (1985). 2008;105:260\u20135.","journal-title":"J Appl Physiol (1985)"},{"key":"7690_CR115","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.90100.2007","volume":"88","author":"BK Pedersen","year":"2008","unstructured":"Pedersen BK, Febbraio MA. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev. 2008;88:1379\u2013406.","journal-title":"Physiol Rev"},{"key":"7690_CR116","doi-asserted-by":"publisher","first-page":"4146","DOI":"10.3390\/cancers16244146","volume":"16","author":"O Akdogan","year":"2024","unstructured":"Akdogan O, Turkmen S, Uyar GC, Yucel KB, Tufekci B, Gurler F, Yazici O, Ozdemir N, Ozet A, Karakaya C, Sutcuoglu O. Impact of serum GDF-15 and IL-6 on immunotherapy response in cancer: A prospective study. Cancers (Basel). 2024;16:4146.","journal-title":"Cancers (Basel)"},{"key":"7690_CR117","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/antiox13040450","volume":"13","author":"M Monserrat-Mesquida","year":"2024","unstructured":"Monserrat-Mesquida M, Quetglas-Llabr\u00e9s MM, Bouzas C, Garc\u00eda S, Mateos D, Ugarriza L, G\u00f3mez C, Tur JA, Sureda A. Effects of regular exercise on the Biochemical, Oxidative, and inflammatory profiles and quality of life in older Spaniards with metabolic syndrome. Antioxid (Basel). 2024;13:450.","journal-title":"Antioxid (Basel)"},{"key":"7690_CR118","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s00421-009-1145-z","volume":"107","author":"TW Buford","year":"2009","unstructured":"Buford TW, Cooke MB, Willoughby DS. Resistance exercise-induced changes of inflammatory gene expression within human skeletal muscle. Eur J Appl Physiol. 2009;107:463\u201371.","journal-title":"Eur J Appl Physiol"},{"key":"7690_CR119","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1519\/JSC.0b013e3181cc2212","volume":"24","author":"MD Phillips","year":"2010","unstructured":"Phillips MD, Mitchell JB, Currie-Elolf LM, Yellott RC, Hubing KA. Influence of commonly employed resistance exercise protocols on Circulating IL-6 and indices of insulin sensitivity. J Strength Cond Res. 2010;24:1091\u2013101.","journal-title":"J Strength Cond Res"},{"key":"7690_CR120","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1016\/j.bbrc.2003.09.048","volume":"310","author":"P Keller","year":"2003","unstructured":"Keller P, Keller C, Carey AL, Jauffred S, Fischer CP, Steensberg A, Pedersen BK. Interleukin-6 production by contracting human skeletal muscle: autocrine regulation by IL-6. Biochem Biophys Res Commun. 2003;310:550\u20134.","journal-title":"Biochem Biophys Res Commun"},{"key":"7690_CR121","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1152\/japplphysiol.00164.2004","volume":"98","author":"AM Petersen","year":"2005","unstructured":"Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol (1985). 2005;98:1154\u201362.","journal-title":"J Appl Physiol (1985)"},{"key":"7690_CR122","doi-asserted-by":"publisher","first-page":"101293","DOI":"10.1016\/j.mam.2024.101293","volume":"99","author":"E Tamayo-Torres","year":"2024","unstructured":"Tamayo-Torres E, Garrido A, de Cabo R, Carretero J, G\u00f3mez-Cabrera MC. Molecular mechanisms of cancer cachexia. Role of exercise training. Mol Aspects Med. 2024;99:101293.","journal-title":"Mol Aspects Med"},{"key":"7690_CR123","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1519\/JSC.0b013e3181876a9a","volume":"23","author":"Y Meckel","year":"2009","unstructured":"Meckel Y, Eliakim A, Seraev M, Zaldivar F, Cooper DM, Sagiv M, Nemet D. The effect of a brief sprint interval exercise on growth factors and inflammatory mediators. J Strength Cond Res. 2009;23:225\u201330.","journal-title":"J Strength Cond Res"},{"key":"7690_CR124","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1519\/JSC.0b013e3181dc4571","volume":"25","author":"Y Meckel","year":"2011","unstructured":"Meckel Y, Nemet D, Bar-Sela S, Radom-Aizik S, Cooper DM, Sagiv M, Eliakim A. Hormonal and inflammatory responses to different types of sprint interval training. J Strength Cond Res. 2011;25:2161\u20139.","journal-title":"J Strength Cond Res"},{"key":"7690_CR125","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imj.12625","volume":"45","author":"M Comassi","year":"2015","unstructured":"Comassi M, Vitolo E, Pratali L, Del Turco S, Dellanoce C, Rossi C, Santini E, Solini A. Acute effects of different degrees of ultra-endurance exercise on systemic inflammatory responses. Intern Med J. 2015;45:74\u20139.","journal-title":"Intern Med J"},{"key":"7690_CR126","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1139\/apnm-2020-0783","volume":"46","author":"SA Vardar","year":"2021","unstructured":"Vardar SA, Do\u011fanlar ZB, Kaya O, Tayfur P, Sut N, Do\u011fanlar O. Different responses of apoptotic, inflammatory and heat shock protein gene expression to a single bout of high-intensity interval exercise between physically active and inactive men. Appl Physiol Nutr Metab. 2021;46:743\u201352.","journal-title":"Appl Physiol Nutr Metab"},{"key":"7690_CR127","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1515\/hukin-2017-0031","volume":"56","author":"L Cipryan","year":"2017","unstructured":"Cipryan L. IL-6, antioxidant capacity and muscle damage markers following High-Intensity interval training protocols. J Hum Kinet. 2017;56:139\u201348.","journal-title":"J Hum Kinet"},{"key":"7690_CR128","doi-asserted-by":"publisher","first-page":"e0138853","DOI":"10.1371\/journal.pone.0138853","volume":"10","author":"G Fisher","year":"2015","unstructured":"Fisher G, Brown AW, Bohan Brown MM, Alcorn A, Noles C, Winwood L, Resuehr H, George B, Jeansonne MM, Allison DB. High intensity Interval- vs moderate intensity- training for improving cardiometabolic health in overweight or obese males: A randomized controlled trial. PLoS ONE. 2015;10:e0138853.","journal-title":"PLoS ONE"},{"key":"7690_CR129","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/13813455.2018.1437750","volume":"125","author":"FM Steckling","year":"2019","unstructured":"Steckling FM, Farinha JB, Figueiredo FDC, Santos DLD, Bresciani G, Kretzmann NA, Stefanello ST, Courtes AA, Beck MO, Sangoi Cardoso M, et al. High-intensity interval training improves inflammatory and adipokine profiles in postmenopausal women with metabolic syndrome. Arch Physiol Biochem. 2019;125:85\u201391.","journal-title":"Arch Physiol Biochem"},{"key":"7690_CR130","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0031-1299694","volume":"44","author":"FS Lira","year":"2012","unstructured":"Lira FS, Yamashita AS, Rosa JC, Koyama CH, Caperuto EC, Batista ML Jr., Seelaender MC. Exercise training decreases adipose tissue inflammation in cachectic rats. Horm Metab Res. 2012;44:91\u20138.","journal-title":"Horm Metab Res"},{"key":"7690_CR131","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.3390\/antiox12101847","volume":"12","author":"D Reljic","year":"2023","unstructured":"Reljic D, Koller A, Herrmann HJ, Ekici AB, Neurath MF, Zopf Y. Differential effects of Very-Low-Volume exercise modalities on telomere Length, Inflammation, and cardiometabolic health in obese metabolic syndrome patients: A subanalysis from two randomized controlled trials. Antioxid (Basel). 2023;12:1847.","journal-title":"Antioxid (Basel)"},{"key":"7690_CR132","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1111\/j.1532-5415.2008.01994.x","volume":"56","author":"BJ Nicklas","year":"2008","unstructured":"Nicklas BJ, Hsu FC, Brinkley TJ, Church T, Goodpaster BH, Kritchevsky SB, Pahor M. Exercise training and plasma C-reactive protein and interleukin-6 in elderly people. J Am Geriatr Soc. 2008;56:2045\u201352.","journal-title":"J Am Geriatr Soc"},{"key":"7690_CR133","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1038\/onc.2011.517","volume":"31","author":"S Yoon","year":"2012","unstructured":"Yoon S, Woo SU, Kang JH, Kim K, Shin HJ, Gwak HS, Park S, Chwae YJ. NF-\u03baB and STAT3 cooperatively induce IL6 in starved cancer cells. Oncogene. 2012;31:3467\u201381.","journal-title":"Oncogene"},{"key":"7690_CR134","doi-asserted-by":"publisher","first-page":"5590","DOI":"10.1158\/1078-0432.CCR-04-2561","volume":"11","author":"K Kuroda","year":"2005","unstructured":"Kuroda K, Horiguchi Y, Nakashima J, Kikuchi E, Kanao K, Miyajima A, Ohigashi T, Umezawa K, Murai M. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer. Clin Cancer Res. 2005;11:5590\u20134.","journal-title":"Clin Cancer Res"},{"key":"7690_CR135","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/jcsm.13109","volume":"14","author":"I Pototschnig","year":"2023","unstructured":"Pototschnig I, Feiler U, Diwoky C, Vesely PW, Rauchenwald T, Paar M, Bakiri L, Pajed L, Hofer P, Kashofer K, et al. Interleukin-6 initiates muscle- and adipose tissue wasting in a novel C57BL\/6 model of cancer-associated cachexia. J Cachexia Sarcopenia Muscle. 2023;14:93\u2013107.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"7690_CR136","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.pan.2018.11.002","volume":"19","author":"ML Ramsey","year":"2019","unstructured":"Ramsey ML, Talbert E, Ahn D, Bekaii-Saab T, Badi N, Bloomston PM, Conwell DL, Cruz-Monserrate Z, Dillhoff M, Farren MR, et al. Circulating interleukin-6 is associated with disease progression, but not cachexia in pancreatic cancer. Pancreatology. 2019;19:80\u20137.","journal-title":"Pancreatology"},{"key":"7690_CR137","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/jcsm.13491","volume":"15","author":"MS Yule","year":"2024","unstructured":"Yule MS, Thompson J, Leesahatsawat K, Sousa MS, Anker SD, Arends J, Balstad TR, Brown LR, Bye A, Dajani O, et al. Biomarker endpoints in cancer cachexia clinical trials: systematic review 5 of the cachexia endpoint series. J Cachexia Sarcopenia Muscle. 2024;15:853\u201367.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"7690_CR138","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/sms.14241","volume":"33","author":"D Nash","year":"2023","unstructured":"Nash D, Hughes MG, Butcher L, Aicheler R, Smith P, Cullen T, Webb R. IL-6 signaling in acute exercise and chronic training: potential consequences for health and athletic performance. Scand J Med Sci Sports. 2023;33:4\u201319.","journal-title":"Scand J Med Sci Sports"},{"key":"7690_CR139","doi-asserted-by":"publisher","first-page":"e23596","DOI":"10.1096\/fj.202301619R","volume":"38","author":"M Ringleb","year":"2024","unstructured":"Ringleb M, Javelle F, Haunhorst S, Bloch W, Fennen L, Baumgart S, Drube S, Reuken PA, Pletz MW, Wagner H, et al. Beyond muscles: investigating immunoregulatory myokines in acute resistance exercise - A systematic review and meta-analysis. Faseb J. 2024;38:e23596.","journal-title":"Faseb J"},{"key":"7690_CR140","first-page":"2005","volume":"2023","author":"M Ringleb","year":"2023","unstructured":"Ringleb M, Javelle F, Haunhorst S, Bloch W, Fennen L, Baumgart S, Drube S, Reuken P, Pletz MW, Wagner H. Acute resistance exercise-induced changes in IL-6, IL-10, and IL-1ra in healthy adults: a systematic review and meta-analysis. MedRxiv. 2023;2023:2005\u201310. 23289790.","journal-title":"MedRxiv"},{"key":"7690_CR141","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.3390\/ijms23073501","volume":"23","author":"BEM Zunner","year":"2022","unstructured":"Zunner BEM, Wachsmuth NB, Eckstein ML, Scherl L, Schierbauer JR, Haupt S, Stumpf C, Reusch L, Moser O. Myokines and resistance training: A narrative review. Int J Mol Sci. 2022;23:3501.","journal-title":"Int J Mol Sci"},{"key":"7690_CR142","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/bjc.2016.3","volume":"114","author":"CA Penafuerte","year":"2016","unstructured":"Penafuerte CA, Gagnon B, Sirois J, Murphy J, MacDonald N, Tremblay ML. Identification of neutrophil-derived proteases and angiotensin II as biomarkers of cancer cachexia. Br J Cancer. 2016;114:680\u20137.","journal-title":"Br J Cancer"},{"key":"7690_CR143","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1093\/jnci\/djaf062","volume":"117","author":"F Bettariga","year":"2025","unstructured":"Bettariga F, Taaffe DR, Borsati A, Avancini A, Pilotto S, Lazzarini SG, Lopez P, Maestroni L, Crainich U, Campbell JP, et al. Effects of exercise on inflammation in female survivors of nonmetastatic breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2025;117:1984\u201398.","journal-title":"J Natl Cancer Inst"},{"key":"7690_CR144","first-page":"566","volume":"33","author":"J Vo\u00df","year":"2025","unstructured":"Vo\u00df J, Barisch J, Thieme R, Gockel I, Tegtbur U, Leps C, Busse M, Falz R. Home-based online exercise training and chronic, low-grade inflammation in cancer patients after curative surgery: secondary analysis of the randomized controlled multicenter CRBP-TS trial. Support Care Cancer. 2025;33:566.","journal-title":"Support Care Cancer"},{"key":"7690_CR145","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s11255-019-02200-7","volume":"51","author":"ZJ Dong","year":"2019","unstructured":"Dong ZJ, Zhang HL, Yin LX. Effects of intradialytic resistance exercise on systemic inflammation in maintenance Hemodialysis patients with sarcopenia: a randomized controlled trial. Int Urol Nephrol. 2019;51:1415\u201324.","journal-title":"Int Urol Nephrol"},{"key":"7690_CR146","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.tem.2023.08.001","volume":"34","author":"ST Orange","year":"2023","unstructured":"Orange ST, Leslie J, Ross M, Mann DA, Wackerhage H. The exercise IL-6 enigma in cancer. Trends Endocrinol Metab. 2023;34:749\u201363.","journal-title":"Trends Endocrinol Metab"},{"key":"7690_CR147","doi-asserted-by":"publisher","first-page":"397","DOI":"10.21873\/anticanres.15498","volume":"42","author":"NR Wood","year":"2022","unstructured":"Wood NR, Garritson J, Mathias A, Haughian JM, Hayward R. Moderate intensity endurance and resistance exercise attenuates cachexia in Tumor-bearing mice. Anticancer Res. 2022;42:397\u2013405.","journal-title":"Anticancer Res"},{"key":"7690_CR148","doi-asserted-by":"publisher","first-page":"101829","DOI":"10.1016\/j.arr.2022.101829","volume":"84","author":"P Fang","year":"2023","unstructured":"Fang P, She Y, Yu M, Min W, Shang W, Zhang Z. Adipose-Muscle crosstalk in age-related metabolic disorders: the emerging roles of adipo-myokines. Ageing Res Rev. 2023;84:101829.","journal-title":"Ageing Res Rev"},{"key":"7690_CR149","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1002\/oby.20402","volume":"21","author":"AG Oliveira","year":"2013","unstructured":"Oliveira AG, Araujo TG, Carvalho BM, Guadagnini D, Rocha GZ, Bagarolli RA, Carvalheira JB, Saad MJ. Acute exercise induces a phenotypic switch in adipose tissue macrophage polarization in diet-induced obese rats. Obes (Silver Spring). 2013;21:2545\u201356.","journal-title":"Obes (Silver Spring)"},{"key":"7690_CR150","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00280-023-04576-x","volume":"92","author":"JHC Nunes","year":"2023","unstructured":"Nunes JHC, Cella PS, Guimar\u00e3es TAS, Bu\u00e7u IP, Deminice R. Chemotherapy periodization to maximize resistance training adaptations in oncology. Cancer Chemother Pharmacol. 2023;92:357\u201367.","journal-title":"Cancer Chemother Pharmacol"},{"key":"7690_CR151","doi-asserted-by":"publisher","first-page":"880787","DOI":"10.3389\/fonc.2022.880787","volume":"12","author":"MTJ Testa","year":"2022","unstructured":"Testa MTJ, Cella PS, Marinello PC, Frajacomo FTT, Padilha CS, Perandini PC, Moura FA, Duarte JA, Cecchini R, Guarnier FA, Deminice R. Resistance training attenuates activation of STAT3 and muscle atrophy in Tumor-Bearing mice. Front Oncol. 2022;12:880787.","journal-title":"Front Oncol"},{"key":"7690_CR152","doi-asserted-by":"publisher","first-page":"E1042","DOI":"10.1152\/ajpendo.00410.2012","volume":"304","author":"JP White","year":"2013","unstructured":"White JP, Puppa MJ, Gao S, Sato S, Welle SL, Carson JA. Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK. Am J Physiol Endocrinol Metab. 2013;304:E1042\u20131052.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"7690_CR153","doi-asserted-by":"publisher","first-page":"19940","DOI":"10.1038\/s41598-022-17439-x","volume":"12","author":"M G\u00f3recka","year":"2022","unstructured":"G\u00f3recka M, Krzemi\u0144ski K, Mikulski T, Ziemba AW. ANGPTL4, IL-6 and TNF-\u03b1 as regulators of lipid metabolism during a marathon run. Sci Rep. 2022;12:19940.","journal-title":"Sci Rep"},{"key":"7690_CR154","doi-asserted-by":"publisher","first-page":"C128","DOI":"10.1152\/ajpcell.00025.2012","volume":"304","author":"M Hoene","year":"2013","unstructured":"Hoene M, Runge H, H\u00e4ring HU, Schleicher ED, Weigert C. Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway. Am J Physiol Cell Physiol. 2013;304:C128\u2013136.","journal-title":"Am J Physiol Cell Physiol"},{"key":"7690_CR155","doi-asserted-by":"publisher","first-page":"188761","DOI":"10.1016\/j.bbcan.2022.188761","volume":"1877","author":"Q Huang","year":"2022","unstructured":"Huang Q, Wu M, Wu X, Zhang Y, Xia Y. Muscle-to-tumor crosstalk: the effect of exercise-induced myokine on cancer progression. Biochim Biophys Acta Rev Cancer. 2022;1877:188761.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7690_CR156","doi-asserted-by":"crossref","unstructured":"Manole E, Ceafalan LC, Popescu BO, Dumitru C, Bastian AE. Myokines as possible therapeutic targets in cancer cachexia. J Immunol Res. 2018;2018:8260742.","DOI":"10.1155\/2018\/8260742"},{"key":"7690_CR157","doi-asserted-by":"publisher","first-page":"e69","DOI":"10.1200\/JCO.2012.44.2020","volume":"31","author":"K Ando","year":"2013","unstructured":"Ando K, Takahashi F, Motojima S, Nakashima K, Kaneko N, Hoshi K, Takahashi K. Possible role for tocilizumab, an anti-interleukin-6 receptor antibody, in treating cancer cachexia. J Clin Oncol. 2013;31:e69\u201372.","journal-title":"J Clin Oncol"},{"key":"7690_CR158","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.jpainsymman.2013.01.009","volume":"46","author":"H Hirata","year":"2013","unstructured":"Hirata H, Tetsumoto S, Kijima T, Kida H, Kumagai T, Takahashi R, Otani Y, Inoue K, Kuhara H, Shimada K, et al. Favorable responses to Tocilizumab in two patients with cancer-related cachexia. J Pain Symptom Manage. 2013;46:e9\u201313.","journal-title":"J Pain Symptom Manage"},{"key":"7690_CR159","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antiox12051075","volume":"12","author":"O Abu Shelbayeh","year":"2023","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB. PGC-1\u03b1 is a master regulator of mitochondrial lifecycle and ROS stress response. Antioxid (Basel). 2023;12:1075.","journal-title":"Antioxid (Basel)"},{"key":"7690_CR160","doi-asserted-by":"publisher","first-page":"660068","DOI":"10.3389\/fphys.2021.660068","volume":"12","author":"D Sorriento","year":"2021","unstructured":"Sorriento D, Di Vaia E, Iaccarino G. Physical exercise: A novel tool to protect mitochondrial health. Front Physiol. 2021;12:660068.","journal-title":"Front Physiol"},{"key":"7690_CR161","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.3390\/cells10102639","volume":"10","author":"FL Roberts","year":"2021","unstructured":"Roberts FL, Markby GR. New insights into molecular mechanisms mediating adaptation to Exercise; A review focusing on mitochondrial Biogenesis, mitochondrial Function, mitophagy and autophagy. Cells. 2021;10:2639.","journal-title":"Cells"},{"key":"7690_CR162","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1152\/japplphysiol.00242.2003","volume":"95","author":"C MacDonald","year":"2003","unstructured":"MacDonald C, Wojtaszewski JF, Pedersen BK, Kiens B, Richter EA. Interleukin-6 release from human skeletal muscle during exercise: relation to AMPK activity. J Appl Physiol (1985). 2003;95:2273\u20137.","journal-title":"J Appl Physiol (1985)"},{"key":"7690_CR163","doi-asserted-by":"publisher","first-page":"100396","DOI":"10.1016\/j.xcrm.2021.100396","volume":"2","author":"B Trinh","year":"2021","unstructured":"Trinh B, Peletier M, Simonsen C, Plomgaard P, Karstoft K, Klarlund Pedersen B, van Hall G, Ellingsgaard H. Blocking endogenous IL-6 impairs mobilization of free fatty acids during rest and exercise in lean and obese men. Cell Rep Med. 2021;2:100396.","journal-title":"Cell Rep Med"},{"key":"7690_CR164","doi-asserted-by":"publisher","first-page":"102042","DOI":"10.1016\/j.xcrm.2025.102042","volume":"6","author":"B Trinh","year":"2025","unstructured":"Trinh B, Rasmussen SJ, Br\u00f8gger-Jensen ME, Engelhard CA, Lund A, Tavanez AR, Vassilieva A, Janum S, Iepsen UW, Kiens B, et al. Inhibition of basal IL-6 activity promotes subcutaneous fat retention in humans during fasting and postprandial States. Cell Rep Med. 2025;6:102042.","journal-title":"Cell Rep Med"},{"key":"7690_CR165","doi-asserted-by":"publisher","first-page":"E2","DOI":"10.1152\/ajpendo.00274.2004","volume":"289","author":"N Hiscock","year":"2005","unstructured":"Hiscock N, Fischer C, Sacchetti M, van Hall G, Febbraio M, Pedersen B. Recombinant human interleukin-6 infusion during low-intensity exercise does not enhance whole body lipolysis or fat oxidation in humans. Am J Physiology-Endocrinology Metabolism. 2005;289:E2\u20137.","journal-title":"Am J Physiology-Endocrinology Metabolism"},{"key":"7690_CR166","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.2337\/db08-1293","volume":"58","author":"M Kelly","year":"2009","unstructured":"Kelly M, Gauthier MS, Saha AK, Ruderman NB. Activation of AMP-activated protein kinase by interleukin-6 in rat skeletal muscle: association with changes in cAMP, energy state, and endogenous fuel mobilization. Diabetes. 2009;58:1953\u201360.","journal-title":"Diabetes"},{"key":"7690_CR167","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.bbrc.2004.05.188","volume":"320","author":"M Kelly","year":"2004","unstructured":"Kelly M, Keller C, Avilucea PR, Keller P, Luo Z, Xiang X, Giralt M, Hidalgo J, Saha AK, Pedersen BK. AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun. 2004;320:449\u201354.","journal-title":"Biochem Biophys Res Commun"},{"key":"7690_CR168","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.cmet.2018.12.007","volume":"29","author":"AS Wedell-Neergaard","year":"2019","unstructured":"Wedell-Neergaard AS, Lang Lehrskov L, Christensen RH, Legaard GE, Dorph E, Larsen MK, Launbo N, Fagerlind SR, Seide SK, Nymand S, et al. Exercise-Induced changes in visceral adipose tissue mass are regulated by IL-6 signaling: A randomized controlled trial. Cell Metab. 2019;29:844\u2013e855843.","journal-title":"Cell Metab"},{"key":"7690_CR169","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1042\/BJ20111451","volume":"441","author":"J Lee","year":"2012","unstructured":"Lee J, Giordano S, Zhang J. Autophagy, mitochondria and oxidative stress: cross-talk and redox signalling. Biochem J. 2012;441:523\u201340.","journal-title":"Biochem J"},{"key":"7690_CR170","doi-asserted-by":"publisher","first-page":"5135","DOI":"10.1113\/JP270654","volume":"594","author":"TL Merry","year":"2016","unstructured":"Merry TL, Ristow M. Do antioxidant supplements interfere with skeletal muscle adaptation to exercise training? J Physiol. 2016;594:5135\u201347.","journal-title":"J Physiol"},{"key":"7690_CR171","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1042\/BST0351295","volume":"35","author":"BK Pedersen","year":"2007","unstructured":"Pedersen BK. IL-6 signalling in exercise and disease. Biochem Soc Trans. 2007;35:1295\u20137.","journal-title":"Biochem Soc Trans"},{"key":"7690_CR172","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nature07206","volume":"454","author":"C Handschin","year":"2008","unstructured":"Handschin C, Spiegelman BM. The role of exercise and PGC1alpha in inflammation and chronic disease. Nature. 2008;454:463\u20139.","journal-title":"Nature"},{"key":"7690_CR173","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nri3041","volume":"11","author":"M Gleeson","year":"2011","unstructured":"Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011;11:607\u201315.","journal-title":"Nat Rev Immunol"},{"key":"7690_CR174","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1249\/00003677-199800260-00004","volume":"26","author":"GR Adams","year":"1998","unstructured":"Adams GR. Role of insulin-like growth factor-I in the regulation of skeletal muscle adaptation to increased loading. Exerc Sport Sci Rev. 1998;26:31\u201360.","journal-title":"Exerc Sport Sci Rev"},{"key":"7690_CR175","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1038\/nm.2513","volume":"17","author":"H Ellingsgaard","year":"2011","unstructured":"Ellingsgaard H, Hauselmann I, Schuler B, Habib AM, Baggio LL, Meier DT, Eppler E, Bouzakri K, Wueest S, Muller YD, et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med. 2011;17:1481\u20139.","journal-title":"Nat Med"},{"key":"7690_CR176","doi-asserted-by":"crossref","unstructured":"Stumpf F, Keller B, Gressies C, Schuetz P. Inflammation and nutrition: Friend or foe? Nutrients. 2023;15:1159.","DOI":"10.3390\/nu15051159"},{"key":"7690_CR177","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.tem.2021.03.007","volume":"32","author":"T Siff","year":"2021","unstructured":"Siff T, Parajuli P, Razzaque MS, Atfi A. Cancer-Mediated muscle cachexia: etiology and clinical management. Trends Endocrinol Metab. 2021;32:382\u2013402.","journal-title":"Trends Endocrinol Metab"},{"key":"7690_CR178","doi-asserted-by":"publisher","first-page":"672","DOI":"10.33588\/rn.4511.2006612","volume":"45","author":"DE Cintra","year":"2007","unstructured":"Cintra DE, Ropelle ER, Pauli JR. [Brain regulation of food intake and expenditure energy: molecular action of insulin, leptin and physical exercise]. Rev Neurol. 2007;45:672\u201382.","journal-title":"Rev Neurol"},{"key":"7690_CR179","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/s41574-019-0174-x","volume":"15","author":"BK Pedersen","year":"2019","unstructured":"Pedersen BK. Physical activity and muscle-brain crosstalk. Nat Rev Endocrinol. 2019;15:383\u201392.","journal-title":"Nat Rev Endocrinol"},{"key":"7690_CR180","doi-asserted-by":"publisher","first-page":"e000398","DOI":"10.3945\/cdn.116.000398","volume":"1","author":"S Hunschede","year":"2017","unstructured":"Hunschede S, Kubant R, Akilen R, Thomas S, Anderson GH. Decreased appetite after High-Intensity exercise correlates with increased plasma Interleukin-6 in Normal-Weight and Overweight\/Obese boys. Curr Dev Nutr. 2017;1:e000398.","journal-title":"Curr Dev Nutr"},{"key":"7690_CR181","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1200\/JCO.22.00687","volume":"40","author":"JA Ligibel","year":"2022","unstructured":"Ligibel JA, Bohlke K, May AM, Clinton SK, Demark-Wahnefried W, Gilchrist SC, Irwin ML, Late M, Mansfield S, Marshall TF, et al. Exercise, Diet, and weight management during cancer treatment: ASCO guideline. J Clin Oncol. 2022;40:2491\u2013507.","journal-title":"J Clin Oncol"},{"key":"7690_CR182","doi-asserted-by":"publisher","first-page":"100092","DOI":"10.1016\/j.esmoop.2021.100092","volume":"6","author":"J Arends","year":"2021","unstructured":"Arends J, Strasser F, Gonella S, Solheim TS, Madeddu C, Ravasco P, Buonaccorso L, de van der Schueren MAE, Baldwin C, Chasen M, Ripamonti CI. Cancer cachexia in adult patients: ESMO clinical practice Guidelines(\u2606). ESMO Open. 2021;6:100092.","journal-title":"ESMO Open"},{"key":"7690_CR183","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.tips.2007.02.002","volume":"28","author":"BK Pedersen","year":"2007","unstructured":"Pedersen BK, Fischer CP. Beneficial health effects of exercise\u2013the role of IL-6 as a myokine. Trends Pharmacol Sci. 2007;28:152\u20136.","journal-title":"Trends Pharmacol Sci"},{"key":"7690_CR184","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/jcsm.13638","volume":"15","author":"Y Du","year":"2024","unstructured":"Du Y, Liu XY, Pan RL, Zhang XT, Si XY, Chen MJ, Wang MZ, Zhang L. Tocilizumab for advanced Non-Small-Cell lung cancer with concomitant cachexia: an observational study. J Cachexia Sarcopenia Muscle. 2024;15:2815\u201325.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"7690_CR185","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1517\/14712598.2011.627850","volume":"11","author":"TJ Bayliss","year":"2011","unstructured":"Bayliss TJ, Smith JT, Schuster M, Dragnev KH, Rigas JR. A humanized anti-IL-6 antibody (ALD518) in non-small cell lung cancer. Expert Opin Biol Ther. 2011;11:1663\u20138.","journal-title":"Expert Opin Biol Ther"},{"key":"7690_CR186","doi-asserted-by":"publisher","first-page":"1477310","DOI":"10.3389\/fimmu.2024.1477310","volume":"15","author":"P Chen","year":"2024","unstructured":"Chen P, Wang D, Zhan Z, Chen L, Chen Y. Tocilizumab in combination with corticosteroids: potential for managing cancer cachexia with systemic hyperinflammation. Front Immunol. 2024;15:1477310.","journal-title":"Front Immunol"},{"key":"7690_CR187","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1182\/blood.V84.8.2472.2472","volume":"84","author":"D Emilie","year":"1994","unstructured":"Emilie D, Wijdenes J, Gisselbrecht C, Jarrousse B, Billaud E, Blay JY, Gabarre J, Gaillard JP, Brochier J, Raphael M. Administration of an anti-interleukin-6 monoclonal antibody to patients with acquired immunodeficiency syndrome and lymphoma: effect on lymphoma growth and on B clinical symptoms. Blood. 1994;84:2472\u20139.","journal-title":"Blood"},{"key":"7690_CR188","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/(SICI)1097-0215(19970729)72:3<424::AID-IJC9>3.0.CO;2-R","volume":"72","author":"JY Blay","year":"1997","unstructured":"Blay JY, Rossi JF, Wijdenes J, Menetrier-Caux C, Schemann S, N\u00e9grier S, Philip T, Favrot M. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma. Int J Cancer. 1997;72:424\u201330.","journal-title":"Int J Cancer"},{"key":"7690_CR189","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1002\/pros.21362","volume":"71","author":"J Karkera","year":"2011","unstructured":"Karkera J, Steiner H, Li W, Skradski V, Moser PL, Riethdorf S, Reddy M, Puchalski T, Safer K, Prabhakar U, et al. The anti-interleukin-6 antibody Siltuximab down-regulates genes implicated in tumorigenesis in prostate cancer patients from a phase I study. Prostate. 2011;71:1455\u201365.","journal-title":"Prostate"},{"key":"7690_CR190","doi-asserted-by":"publisher","first-page":"e396","DOI":"10.1038\/bcj.2016.4","volume":"6","author":"JJ Shah","year":"2016","unstructured":"Shah JJ, Feng L, Thomas SK, Berkova Z, Weber DM, Wang M, Qazilbash MH, Champlin RE, Mendoza TR, Cleeland C, Orlowski RZ. Siltuximab (CNTO 328) with lenalidomide, bortezomib and dexamethasone in newly-diagnosed, previously untreated multiple myeloma: an open-label phase I trial. Blood Cancer J. 2016;6:e396.","journal-title":"Blood Cancer J"},{"key":"7690_CR191","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1200\/JCO.23.01965","volume":"43","author":"IM Chen","year":"2025","unstructured":"Chen IM, Johansen JS, Theile S, Silverman LM, Pelz KR, Madsen K, Dajani O, Lim KZM, Lorentzen T, Gaafer O, et al. Randomized phase II study of Nab-Paclitaxel and gemcitabine with or without Tocilizumab as First-Line treatment in advanced pancreatic cancer: survival and cachexia. J Clin Oncol. 2025;43:2107\u201318.","journal-title":"J Clin Oncol"},{"key":"7690_CR192","doi-asserted-by":"crossref","unstructured":"Iyengar NM. Inclusion of exercise in cancer treatment planning: when is the right time? JACC CardioOncol. 2022;4:504\u20136.","DOI":"10.1016\/j.jaccao.2022.10.002"},{"key":"7690_CR193","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1177\/1559827617725283","volume":"13","author":"JP Hardee","year":"2019","unstructured":"Hardee JP, Counts BR, Carson JA. Understanding the role of exercise in cancer cachexia therapy. Am J Lifestyle Med. 2019;13:46\u201360.","journal-title":"Am J Lifestyle Med"},{"key":"7690_CR194","doi-asserted-by":"publisher","first-page":"8011","DOI":"10.3390\/ijms26168011","volume":"26","author":"J Bilski","year":"2025","unstructured":"Bilski J, Szlachcic A, Ptak-Belowska A, Brzozowski T. Physical Activity, Exerkines, and their role in cancer cachexia. Int J Mol Sci. 2025;26:8011.","journal-title":"Int J Mol Sci"},{"key":"7690_CR195","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/SPC.0000000000000091","volume":"8","author":"AA Narsale","year":"2014","unstructured":"Narsale AA, Carson JA. Role of interleukin-6 in cachexia: therapeutic implications. Curr Opin Support Palliat Care. 2014;8:321\u20137.","journal-title":"Curr Opin Support Palliat Care"},{"key":"7690_CR196","first-page":"Cd010804","volume":"3","author":"AJ Grande","year":"2021","unstructured":"Grande AJ, Silva V, Sawaris Neto L, Teixeira Basmage JP, Peccin MS, Maddocks M. Exercise for cancer cachexia in adults. Cochrane Database Syst Rev. 2021;3:Cd010804.","journal-title":"Cochrane Database Syst Rev"},{"key":"7690_CR197","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3390\/antiox7010017","volume":"7","author":"K Suzuki","year":"2018","unstructured":"Suzuki K. Cytokine response to exercise and its modulation. Antioxidants. 2018;7:17.","journal-title":"Antioxidants"},{"key":"7690_CR198","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1074\/jbc.RA117.001163","volume":"293","author":"P Baran","year":"2018","unstructured":"Baran P, Hansen S, Waetzig GH, Akbarzadeh M, Lamertz L, Huber HJ, Ahmadian MR, Moll JM, Scheller J. The balance of Interleukin (IL)-6, IL-6\u00b7 soluble IL-6 receptor (sIL-6R), and IL-6\u00b7 sIL-6R\u00b7 sgp130 complexes allows simultaneous classic and trans-signaling. J Biol Chem. 2018;293:6762\u201375.","journal-title":"J Biol Chem"},{"key":"7690_CR199","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1093\/jncimonographs\/lgad006","volume":"2023","author":"LA Gilmore","year":"2023","unstructured":"Gilmore LA, Parry TL, Thomas GA, Khamoui AV. Skeletal muscle omics signatures in cancer cachexia: perspectives and opportunities. JNCI Monogr. 2023;2023:30\u201342.","journal-title":"JNCI Monogr"},{"key":"7690_CR200","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1093\/jnci\/djac108","volume":"114","author":"RB Parikh","year":"2022","unstructured":"Parikh RB, Basen-Enquist KM, Bradley C, Estrin D, Levy M, Lichtenfeld JL, Malin B, McGraw D, Meropol NJ, Oyer RA. Digital health applications in oncology: an opportunity to seize. J Natl Cancer Inst. 2022;114:1338\u20139.","journal-title":"J Natl Cancer Inst"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07690-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07690-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07690-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T15:03:43Z","timestamp":1770649423000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07690-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":200,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7690"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07690-5","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"27 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}